Dashboard
Manage Tickers

CPIX CUMBERLAND PHARMACEUTICALS INC

Nasdaq cumberlandpharma.com


$ 2.10 $ 0.00 (0 %)    

Thursday, 13-Nov-2025 13:39:33 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 607.05 $ -10.63 (-1.72 %)
DIA $ 474.78 $ -6.61 (-1.37 %)
SPY $ 671.24 $ -9.24 (-1.36 %)
TLT $ 89.54 $ -0.26 (-0.3 %)
GLD $ 382.76 $ -4.62 (-1.19 %)
$ 2.14
$ 2.15
$ 2.01 x 106
$ 2.19 x 300
-- - --
$ 1.04 - $ 7.25
67,319
na
32.01M
$ 0.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 03-07-2025 12-31-2024 10-K
5 11-08-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-13-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-11-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-13-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 05-13-2022 03-31-2022 10-Q
16 03-11-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-13-2021 06-30-2021 10-Q
19 05-14-2021 03-31-2021 10-Q
20 03-12-2021 12-31-2020 10-K
21 11-13-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-22-2020 03-31-2020 10-Q
24 03-20-2020 12-31-2019 10-K
25 11-13-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 03-12-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-09-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 03-13-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-05-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 03-14-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cumberland-q3-adj-eps-006-down-from-002-yoy-sales-8292m-down-from-9086m-yoy
Cumberland Q3 Adj. EPS $(0.06) Down From $...
11/04/2025 22:01:59

Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.06) per share. This is a 200 percent decrease over losses of $(0.02) ...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

Core News & Articles
Cumberland To Co-Commercialize Talicia Wit...
10/20/2025 13:07:09

 Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapyNASHVILLE, Tenn., Oct. ...

Core News & Articles
Cumberland Pharmaceuticals Invests $4M For...
10/20/2025 13:02:59

cumberland-pharma-adds-potent-antibiotic-vibativ-to-national-group-purchasing-agreement-with-premier
Cumberland Pharma Adds Potent Antibiotic, ...
10/13/2025 13:12:44

Premier Membership includes 4,350 U.S. HospitalsNASHVILLE, Tenn., Oct. 13, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc....

cumberland-pharmaceuticals-ibuprofen-injection-receives-mexican-regulatory-approval-to-treat-pain-and-fever-pisa-to-roll-out-product-in-mexico
Cumberland Pharmaceuticals' Ibuprofen Inje...
10/01/2025 13:16:12

Injectable Ibuprofen Approved for Treating Pain & FeverNASHVILLE, Tenn., Oct. 1 , 2025 /PRNewswire/ -- Cumberland Pharmaceu...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
09/19/2025 21:06:05

correction-cumberland-q2-adj-eps-002-up-from-001-yoy-sales-10838m-up-from-9849m-yoy
CORRECTION: Cumberland Q2 Adj. EPS $0.02 U...
08/05/2025 22:04:31

Cumberland (NASDAQ:CPIX) reported quarterly earnings of $0.02 per share. This is a 100 percent increase over earnings of $0.01 ...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

cumberland-pharma-announces-availability-of-vibativ-4-vial-starter-pak-through-new-contract-with-vizient
Cumberland Pharma Announces Availability O...
08/04/2025 13:06:45

Vizient serves more than 65% of the nation's acute care providers, including 97% of academic medical centersNASHVILLE, Tenn...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
07/14/2025 17:06:03

cumberland-pharma-presents-latest-results-from-phase-2-fight-dmd-trial-evaluating-ifetroban-oral-therapy-for-dmd-heart-disease-at-ppmd-conference-in-las-vegas
Cumberland Pharma Presents Latest Results ...
06/23/2025 13:09:18

New pharmacokinetic and cardiac biomarker data further demonstrate ifetroban's potential to protect the heart and reduce ca...

cumberland-pharmaceuticals-publishes-study-investigating-caldolor-in-older-patients
Cumberland Pharmaceuticals Publishes Study...
05/27/2025 20:09:07

cumberland-pharmaceuticals-and-qureight-partner-to-advance-idiopathic-pulmonary-fibrosis-treatment-research
Cumberland Pharmaceuticals And Qureight Pa...
05/13/2025 20:17:26

Cumberland leveraging Qureight's deep-learning AI platform for its Phase II FIGHTING FIBROSIS™ clinical trial

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/06/2025 21:06:18

cumberland-q1-adj-eps-016-up-from-005-yoy-sales-1171m-up-from-850m-yoy
Cumberland Q1 Adj. EPS $0.16 Up From $(0.0...
05/06/2025 20:13:38

Cumberland (NASDAQ:CPIX) reported quarterly earnings of $0.16 per share. This is a 420 percent increase over losses of $(0.05) ...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/21/2025 21:05:50

cumberland-pharmaceuticals-announced-results-from-its-phase-2-fight-dmd-clinical-trial-were-selected-for-late-breaking-presentation-at-the-muscular-dystrophy-association-clinical--scientific-conference-in-dallas
Cumberland Pharmaceuticals Announced Resul...
03/19/2025 20:07:34

Ifetroban demonstrated significant 5.4% improvement in cardiac function

cumberland-q4-adj-eps-002-up-from-011-yoy-sales-1044m-up-from-935m-yoy
Cumberland Q4 Adj EPS $(0.02) Up From $(0....
03/04/2025 21:13:45

Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.02) per share. This is a 81.82 percent increase over losses of $(0.11...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION